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The recent emergence of bacterial pathogens resistant to most or all available antibiotics is among the major global public health
problems. As indirect transmission through contaminated surfaces is a main route of dissemination for most of such pathogens, the
implementation of effective antimicrobial surfaces has been advocated as a promising approach for their containment, especially in the
hospital settings. However, traditional wet synthesis methods of nanoparticle-based antimicrobial materials leave a number of key points
open for metal surfaces: such as adhesion to the surface and nanoparticle coalescence. Here we demonstrate an alternative route, i.e.
supersonic cluster beam deposition, to obtain antimicrobial Ag nanoparticle films deposited directly on surfaces. The synthesized films are
simple to produce with controlled density and thickness, are stable over time, and are shown to be highly bactericidal against major Gram
positive and Gram negative bacterial pathogens, including extensively drug-resistant strains.
From the Clinical Editor: The use of silver nanoparticle in health care is getting more widespread. The authors here describe the technique of
cluster beam deposition for spraying silver on surfaces used in health care sectors. This may open a new avenue for future anti-bacterial coatings.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Key words: Ag nanoparticle-based antimicrobial films; Supersonic cluster beam deposition; Atomic force microscopy; Electron spectroscopies; Bactericidal
activity; Extensively drug-resistant bacteriaBackgrounds
Nanoparticles (NPs) are promising alternatives to conven-
tional materials in many branches of science and technology1-3Abbreviations: NP, nanoparticle; HAI, healthcare-associated infection;
SCBD, supersonic cluster beam deposition; AFM, atomic force microscopy;
XPS, X-ray photoemission spectroscopy; XRD, X-ray diffraction; CFU,
colony forming units; ME, microbicidal effect.
The authors declare no competing financial interests.
The authors disclose any commercial associations, current and within
the past five years, that might pose a potential, perceived or real conflict of
interest to this work. This research was supported in part by Università
Cattolica del Sacro Cuore through D2.2 grants.
⁎Corresponding author. Interdisciplinary Laboratories for Advanced
Material Physics (i-LAMP) & Dipartimento di Matematica e Fisica,
Università Cattolica del Sacro Cuore di Brescia, Brescia, Italy.
E-mail address: luca.gavioli@unicatt.it (L. Gavioli).
Please cite this article as: Cavaliere E, et al, Highly bactericidal Ag nanop
2015;11:1417-1423, http://dx.doi.org/10.1016/j.nano.2015.02.023
http://dx.doi.org/10.1016/j.nano.2015.02.023
1549-9634/© 2015 The Authors. Published by Elsevier Inc. This is an open ac
licenses/by-nc-nd/4.0/).since the nanoscale allows to access physical properties and
functionalities that often differ significantly from their bulk
counterparts. As an example, the antimicrobial activity of
nanomaterials such as fullerenes, TiO2, and Ag NPs has a wide
range of important applications in medicine, water disinfection,
and consumer products (e.g. cosmetics, laundry detergents, toys,
accessories).3-6 In this scenario, a current challenge is the
synthesis and application of NPs7-9 to implement effective
control measures to reduce the incidence of healthcare-
associated infections (HAIs). HAIs have become a global threat
due to the emergence and dissemination of microbial pathogens
that are resistant to most or even all antimicrobial agents
available for their treatment (extensively drug-resistant or
totally drug-resistant phenotypes).10,11 HAIs are in fact a
major cause of patient morbidity and mortality.12 Most of the
principal nosocomial pathogens can asymptomatically colonize
the human host, with colonization representing either a risk
factor for infection or a key step for their dissemination. Indeed,article films obtained by cluster beam deposition. Nanomedicine: NBM
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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infection via the hands of healthcare personnel, who may
become contaminated indirectly by touching contaminated
environmental surfaces.13 Besides the strict adhesion to
hand-hygiene practices and classical environmental cleaning
procedures, the development of antimicrobial surfaces/coatings
characterized by a long-lasting microbicidal effect to be applied
in high-touch hospital devices (e.g. buttons or handles), has been
advocated as a promising approach.11,13 Some of the challenging
aspects concerning fabrication of antimicrobial films are the
adhesion to metal surfaces, determined by the NP–surface
interactions, the ability to maintain the microbicidal effect over
time and the lack of non-wet synthesis methods.
Among the large number of NPs investigated so far for
antimicrobial features, Ag NPs have been considered the most
promising ones for potential medical applications.5 Ag NPs
exert an antibacterial activity through a multifactorial process
which has not been clearly elucidated, and involving either
damaging of bacterial cell wall and plasma membrane, or
inhibition of DNA replication and protein synthesis.14 NP
morphological characteristics (i.e. shape, size) have been proven
to affect antibacterial efficacy of Ag NPs, with a recent work
demonstrating that this could be related to a differential
release of Ag+ ions (i.e. the actual effectors of bactericidal
activity).8
To date, the synthesis of Ag NPs is largely based on wet
chemical reduction starting from a molecular precursor containing
Ag in an oxidized state.15 Such methods allow a great control over
size and shape of theAgNPs, but pose several problems such as the
use of colloidal stabilizers, the presence of impurities, the solvents
and synthesis process costs to reduce or avoid the problem of NP
aggregation in solution.16,17 Moreover, the mere synthesis of
the Ag NPs does not imply a good adhesion of the obtained NPs
to the substrate of need. The layer-by-layer approach16 has been
proposed to obtain surfaces on which thin films/layers of Ag NPs
are deposited or formed as a molecular self-assembled monolayer,
while pre-functionalization of glass has been used to stabilize the
Ag NPs on the surface, further complicating the synthesis and
deposition process.17
A so far unexplored alternative route to Ag NP wet synthesis
is provided by the supersonic cluster beam deposition
(SCBD).18,19 The source is based on the pulsed plasma ablation
of the material to be deposited and the subsequent formation of
an NP beam. The method, which is intrinsically environmen-
tally-friendly since it does not employ solvents, has also been
shown to produce NPs with mixed chemical composition,19
hence allowing the possibility of combining different elements
to engineer the material properties. To our knowledge, this
method has not been applied yet to synthesize Ag NP films with
antimicrobial properties. In the present work, we obtain for the
first time Ag NP films via SCBD directly on the surface of
microscope slides, with an easy control over film thickness
and density. The films are extremely uniform and composed of
pure Ag NPs with an average diameter of 8 nm. Data show that
the NP oxidation state is Ag2O and the films present a high
bactericidal activity against a wide range of clinically relevant
pathogens (including extensively drug-resistant Gram positive
and Gram negative strains).Methods
NP film synthesis and characterization
Nanostructured Ag films were deposited at room temperature
(RT) in medium vacuum (base pressure 1 × 10−6 mbar) condi-
tions by SCBD based on the pulsed microplasma cluster source
(see Figure S1 of Supplementary Materials)18-20 directly on the
surface of soda lime glass (SLG) microscope slides (electron
microscopy sciences). The nominal film thickness and deposi-
tion rate were measured during deposition by a quartz
microbalance, while film physical properties where obtained
ex situ by atomic force microscopy (AFM) (Solver-pro
NT-MDT), X-Ray photoemission spectroscopy (XPS), Auger
Spectroscopy, X-Ray diffraction (XRD) and optical absorption
spectroscopy. Once deposited in the vacuum chamber, the films
are extracted to air and either transferred to the measurement
apparatus or left exposed to the environment. More details on
the experimental characterization procedures can be found in
Supplementary Materials.
Antimicrobial activity of Ag NP films
Antimicrobial activity of Ag NP films was investigated against
a panel of clinically relevant microorganisms, representative of
both Gram negative and Gram positive bacteria, and yeasts. They
included six reference strains (i.e. Escherichia coli ATCC 25922,
Pseudomonas aeruginosa PAO-1, Acinetobacter baumannii
ATCC 17978, Staphylococcus aureus ATCC 6538, Enterococ-
cus faecalis ATCC 29212, Candida albicans ATCC 10231) and
ten clinical strains exhibiting antimicrobial resistance phenotypes
of concern and/or being recognized as members of high-risk
epidemic clones (see Table 1 and references therein21-27 for clinical
strains characteristics).
Antimicrobial activity testing was performed using the
procedure proposed by Pallavicini et al,28 with some minor
modifications. Briefly, 1 ml of an overnight culture was washed
twice with Phosphate Buffered Saline (PBS) pH 7.4, and 10 μl
of microorganism suspension (i.e. range 5.4-7.3 log Colony
Forming Units [CFU], see Table T1 of Supplementary Materials
for details) was deposited both in a glass slide containing the Ag
NP film (challenge slide) and in an unmodified glass slide
(control slide), and a glass coverslip was applied (20 × 20 mm).
After 24 h of incubation at 25 °C in damp environment,
microorganisms were suspended in 10 ml of PBS, appropriately
diluted, and 240 μl of each dilution was plated for viable cell
count (i.e. enumeration of CFU). The log reduction rate was
expressed as Microbicidal Effect (ME), following the formula:
ME = logNC − logNE (where NC and NE represented the
number of CFU obtained with control slides and challenge
slides, respectively). The detection limit of viable cell count was
4.2 × 101 CFU. All microorganisms were tested in three
independent experiments and results were averaged. In order to
calculate standard deviations (SDs), when no viable cells were
counted, the result was arbitrary assumed as 4.2 × 101 CFU,
representing the detection limit value. All microorganisms were
grown aerobically at 37 °C in a shaker incubator (200 rpm) in
Mueller–Hinton II broth (BD, Becton, Dickinson and Company,
Sparks, MD, USA), except for Enterococcus spp. and C.
Table 1
Microbicidal Effect (ME) of Ag NP films against clinically relevant microorganisms after 24 h of exposure.
Strain ME (log CFU ± SD) Strain features
Gram negatives
Escherichia coli ATCC 25922 ≥5.6 ± 0.1 Reference strain
Escherichia coli CVB-1 ≥5.7 ± 0.1 XDR clinical isolate producing the carbapenemase NDM-121
Klebsiella pneumoniae FIPP-1 5.4 ± 0.4 XDR epidemic ST258 clone producing the carbapenemase KPC-322
Klebsiella pneumoniae KKBO-4 5.2 ± 0.7 XDR epidemic ST258 clone producing the carbapenemase KPC-3
and resistant also to colistin23
Pseudomonas aeruginosa PAO-1 ≥5.7 ± 0.3 Reference strain
Pseudomonas aeruginosa VR-143/97 2.6 ± 0.8 XDR epidemic clone producing the carbapenemase VIM-124
Acinetobacter baumannii ATCC 17978 4.2 ± 0.1 Reference strain
Acinetobacter baumannii RUH 134 3.9 ± 0.7 Reference strain for the global clone 225
Acinetobacter baumannii AB06C13 4.2 ± 0.5 XDR clinical isolate belonging to global clone 2 and producing
the carbapenemases OXA-23 and OXA-5826
Gram positives
Staphylococcus aureus ATCC 6538 3.7 ± 0.8 Reference strain
Staphylococcus aureus MRSA-IT16 4.4 ± 0.4 Methicillin-resistant clinical isolate from biofilm-associated infection27
Staphylococcus aureus MRSA-IT1 2.0 ± 0.4 Methicillin-resistant clinical isolate from biofilm-associated infection
and exhibiting hVISA and daptomycin resistance phenotype27
Enterococcus faecalis ATCC 29212 1.7 ± 0.6 Reference strain
Enterococcus faecium FI2013 0.9 ± 0.2 Glycopeptide-resistant clinical isolate from bloodstream infection
Yeasts
Candida albicans ATCC 10231 0.7 ± 0.1 Reference strain
Candida albicans EMO1303 1.0 ± 0.1 Clinical isolate from bloodstream infection
CFU, colony forming unit; SD, standard deviation; XDR, extensively drug resistant isolates exhibiting a resistance phenotype including aminoglycosides,
fluoroquinolones, and β-lactams (including also carbapenems); hVISA, heterogeneous vancomycin-intermediate Staphylococcus aureus.
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Extract-Peptone-Dextrose broth (BD) were used, respectively.
Viable cell count was performed in Sabouraud-Dextrose agar
(Oxoid, Milan, Italy) for C. albicans, and in Luria-Bertani Agar
(LBA) (Oxoid) for all other microorganisms.Results
A representative atomic force microscopy (AFM) image of
the as-deposited NP films synthesized in the present work is
shown in Figure 1, A. The NPs exhibit no signs of fragmentation
and present a very homogeneous distribution (rms rough-
ness b 1 nm) with no coarsening over the entire covered area
(about 15 cm2). This is a common feature in SCBD films due to
the NP soft landing, regardless of the type of compound
deposited.18,19 The average NP size obtained from the AFM data
is around 20 nm (see inset of Figure 1, A). However, this has to
be taken as an upper limit due to the convolution of the NP shape
with the AFM tip (nominal radius 10 nm). X-ray diffraction
data (see Figure S2 of Supplementary Materials) indicate that the
NPs are partly crystalline and have an average crystallographic
domain size of 3.2 ± 0.1 nm, which has to be taken as lower
limit (see description of Figure S2 of Supplementary Materials).
Since the film thickness measured by AFM is 7.8 ± 0.6 nm and
the average height obtained from a statistical analysis of the AFM
images is 3.8 (see Figure S3 of Supplementary Materials), it is
reasonable to consider an average diameter of 7.8 ± 0.6 nm.
Hence the film thickness chosen in the present work corresponds to
a single layer of NPs i.e. 8 nm, with an NP density 70 ± 2 NPs on
an area of 6.25 × 104 nm2, i.e. 1.15 ± 0.04 × 1011 NPs/cm2, as
deduced from the AFM data. Since the film density depends on thedeposition time, it can be easily tuned from a very low coverage
(few percent of the surface area) up to a single layer and beyond.
The chemical state of the NP film has been investigated using
XPS and Auger. The Ag Auger line shape is very sensitive to the
Ag oxidation state.29-31 A comparison of normalized MNN
Auger spectra, obtained from the 8 nm Ag NP film deposited on
the SLG substrate (curve b) and from a polycrystalline, metallic
Ag reference (curve a), is shown in Figure 1, B together with
their difference (curve (b − a)). Spectrum b) presents a broader
line shape, reflected in the difference peak at 351 ± 0.5 eV,
while the feature at 357 ± 0.5 eV is due to the appearance of a
new structure: both consistent with the presence of Ag+ ions.31
The oxidation of the as-deposited NP film is confirmed by the
XPS data shown in Figure 1, C, where the normalized O1s core
levels obtained from the as-deposited Ag NPs (curve b) and from
the clean SLG substrate (curve a) are shown, together with their
difference (curve (b − a)). A least square fitting procedure (see
Figure S4 of Supplementary Materials) shows that the clean SLG
spectrum presents the SiO2 peak at 531.6 eV ± 0.5 eV, and a
shoulder at 530.1 ± 0.5 eV, due to contributions of Na2O and
CaO.32 The data taken on the Ag NP film show an intensity
increase of the shoulder at 530.1 ± 0.5 eV, due to the appearance
of a peak at 530.2 ± 0.5 eV, typical of Ag2O.
32 Although a
possible core-shell structure of NPs with an oxidized shell
surrounding a metallic core cannot be ruled out, the data indicate
that in the synthesized film the NPs are in a Ag2O oxidation state.
This is a required condition for NPs to release Ag+ ions, process
recently proposed as the more relevant mechanism with respect
to the role of the NP size giving rise to the bactericidal activity of
the NPs.8
Since the typical time elapsed between film synthesis and an
antimicrobial activity test was within 15 days, we have analyzed
Figure 1. (A) AFM image of the as-deposited Ag NP film, showing the uniformity at microscopic scale. Inset: high resolution image where the NP size can be
observed. (B) Auger spectra of the as-deposited NP film (curve (b), red dots) and metallic polycrystalline Ag reference (curve (a), black dots), with the difference
spectrum shown in the bottom to highlight the oxidation state of the NP film. (C)XPS spectra of the O1s core level for the as-deposited NP film (curve (b), red dots)
and for the clean microscope slide (curve (a), blue dots), with the difference spectrum shown in the bottom to highlight the oxidation state of the NP film.
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a slight increase of the average NP size, as quantified in Figure 2,
C, showing that the density and the Ag NP size are basically
unchanged. In Figure 2, E we report the Auger data taken at
increasing time intervals that are compared to the as deposited
curve through the difference spectra in the bottom panel. We can
note only a slight intensity increase of the Ag2O component,
suggesting that just after the synthesis some of the NPs (less than
2% according to the intensity variation) are not completely
oxidized. Such increase is also reflected in a sharpening of the
plasmon resonance observed in the optical absorption spectra
shown in Figure 2, D. The broad feature around 480 nm is
consistent with the fact that the NPs are in contact with each other,
hence giving rise to different resonances related to different NP
sizes. The fact that film morphology is not modified as a function
of time, in particular the NP diameter, markedly differentiates this
type of NP films from previously observed backward/forward
reactions observed in colloidal suspensions.33 The overall
emerging picture is that the synthesized films have a very good
stability with respect to coarsening and oxidation state.
Ag NP films were found to exert a broad-spectrum bactericidal
activity, which was demonstrated both with reference strains and
with a collection of clinical strains that exhibited extensively
drug-resistant phenotypes and/or belonged to high-risk hyperepi-
demic clones (see Table 1 and references therein for strains
characteristics).21-27 In particular, after 24 h of exposure to Ag NP
films, a reduction of viable bacterial loads by more than 3 log
(compared to controls) was observed with 10 of the 14 bacterial
strains tested, including representatives of both Gram positive and
Gram negative pathogenic species (Tables 1 and T1 of
Supplementary Materials). Members of the family Enterobacteri-
aceae (i.e. E. coli and K. pneumoniae), which are normal
constituents of the intestinal microbiota and among the most
common causes of HAIs12 showed a consistently very high
susceptibility to Ag NP films (i.e. ME N5 log CFU) (Tables 1 and
T1 of Supplementary Materials). Interestingly, Ag NP films could
almost completely sterilize a high inoculum (i.e. ~1 × 107 CFU)of extensively drug-resistant clinical strains producing two of the
most worrisome resistance mechanisms recently emerged in
enterobacteria and capable of pandemic dissemination, such as
the carbapenemases NDM-type and KPC-type.21-23 An overall
strong bactericidal activity (i.e. ME range N5.7-2.6 log CFU) was
also demonstrated with reference and clinical strains of P.
aeruginosa and A. baumannii, including representative of
extensively drug-resistant high-risk clones (Tables 1 and T1 of
Supplementary Materials). Those microorganisms are major
opportunistic pathogens in the hospital setting, with a high
propensity to evolve extensively drug-resistant and even totally
drug-resistant phenotypes and to survive for long periods in the
hospital environment (accounting for the occurrence of nosoco-
mial epidemics through, for example, contaminated taps, sinks or
even antiseptic solutions).13 The finding of a lower susceptibility to
Ag NP films of the clinical P. aeruginosa VR-143/97 strain
compared to the other four Gram negative non-fermenters tested,
could suggest that this extensively drug-resistant strain might have
evolved some resistance mechanism also to Ag NPs (e.g. by
chromosomal mutations or horizontal gene transfer). Concerning
Gram positive bacteria, high susceptibility to Ag NP films was
demonstrated with two of the three S. aureus tested (ME N3 log
CFU), including a reference strain and a methicillin-resistant strain
isolated from a biofilm-related infection (i.e. naive valve
endocarditis) (Tables 1 and T1 of Supplementary Materials).
Biofilm-forming bacteria are a major challenge in nosocomial
settings, due to their tolerance to antiseptic and antimicrobial
agents, and have been estimated to be responsible for more than
60% of HAIs, mainly associated to the presence of artificial
medical devices (e.g. mechanical ventilators, central venous
catheters, prosthetic devices etc.).34 The S. aureus strain exhibiting
a reduced susceptibility toAgNPs (i.e.ME = 2 logCFU), was also
isolated from a biofilm-associated infection (i.e. post-surgical
wound infection) and was characterized by an uncommon
resistance phenotype extended also to daptomycin (one of the
most recent antibiotic class entered the clinical practice). It could be
hypothesized that the overall reduction of anionic surface charge
Figure 2. (A) AFM image of the as-deposited film; (B) AFM image of the same film after 15 days of exposure to air. (C) NP height distribution obtained from
(a) (bottom) and (b) (top), respectively. (D) Optical absorption spectra as a function of elapsed time after deposition. (E) Auger spectra taken at different time
intervals, with the difference curves in the bottom panel.
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might have contributed to the reduced susceptibility to Ag NPs, by
impairing the interaction with the positively charged silver ions, a
fact that would worth further investigation. Finally, Enterococcus
spp. strains exhibited a relatively low susceptibility to AgNP films
(ME range 0.9-1.7 log CFU), as well as the twoC. albicans strains
(ME range 0.7-1 log CFU) (Tables 1 and T1 of Supplementary
Materials). The poor activity of Ag NPs against the latter
microorganisms is an intriguing phenomenon, and the reasons
accounting for this will deserve further attention. The possibility to
use the flexibility of the SCBD for generating NPs with mixed
chemical composition will allow investigating antimicrobial
features of diverse NP films, with the aim of implementing
antimicrobial surfaces which could include also those important
nosocomial pathogens.Discussion
The Ag antimicrobial properties have been known for long
time, although the synthesis of Ag NPs as antimicrobial material
is relatively recent.15 This has brought to include Ag NPs in a
wide variety of applications14 but also to propose their use ascoatings. However, the transfer from the synthesized NPs from
solutions onto the substrate has evidenced the NP coarsening
effect and the weak bound formed between the NPs and the
substrate.16,17 Recently, for wet-synthesized Ag NPs transferred
on glass, an amino-silanization treatment of the surface has been
proposed17 to increase the adhesion of the coating. The results
presented here demonstrate a completely different route to
synthesize Ag NPs as compared to the wet chemistry approach.
The use of SCBD allows the immediate and direct deposition of
the coating on virtually any substrate, with a perfect control over
the coating thickness and density that are dependent only on
deposition time. Moreover, the synthesis process is completely
free of solvents and produces ultrapure Ag NPs, while it does not
require any pretreatment or formation of a siloxane sol as
mandatory prerequisite to stabilize the Ag NPs obtained by wet
chemistry. The film deposited by SCBD on soda lime glass
substrates presented here have a good stability also with respect to
time (see Figure S5 of SupplementaryMaterials): it is worth noting
that the exposure to air of the SCBD film does not alter its
morphology apart from a very slight coarsening of the NPs, while
the percent of NPs that are oxidized is even improved. Moreover,
the observed film stability with respect to time is comparable to
that of the Ag NP films deposited on amino-silanized surfaces as
1422 E. Cavaliere et al / Nanomedicine: Nanotechnology, Biology, and Medicine 11 (2015) 1417–1423reported by Taglietti et al.17 Concerning the film adhesion to the
SLG surface, we have compared the behavior of the SCBD films
on plane glass and on amino-silanized glass.17 The adhesion of the
film has been tested by employing a home-made scratching test
and subsequently measuring the optical transmission of the film, as
described in the Supplementary Materials. The main result is that
the SCBD film is indeed able to persist after the scratch test,
although the presence of the silanization layer improves the wear
resistance by about 15 %, as indicated by the intensity variation
of the optical transmission (See Figure S5 of Supplementary
Materials). These data confirm that on glass the silanization
pretreatment is able to improve the adhesion, but is however not
necessary in our case to obtain a fairly stable film.
Considering the dimension of the covered area reported in
this experiment it is possible to envisage a scalability of this
technique to larger surfaces and to surfaces of metals without
modification of the proposed synthesis process. It is also worth
noting that the SCBD approach has a large development
potential in terms of control of the Ag NP surface adhesion
through the formation of NPs alloyed with other biocompatible
metals. Such potential has been already suggested by synthesis
of a 95%–5% Ti–Cr alloy where Cr is located in substitutional
sites of the Ti lattice.19
As far as the antimicrobial activity is concerned, the effectiveness
of the film prepared here is relevant and with a broad spectrum.
Indeed, after 24 h of exposure a bactericidal activity (i.e. decrease in
viable cell count ≥99.9%) was observed with most tested bacterial
strains, including representatives of the major clinically relevant
Gram negative and Gram positive pathogens. The notable lower
antimicrobial activity of the Ag NP films obtained in this study
against Enterococcus spp. and C. albicans, and the observation of
reduced susceptibility in some extensively drug-resistant P.
aeruginosa and S. aureus clinical strains, represent a limitation
thatwill be addressed in future studies through the implementation of
NP films with mixed chemical composition.
In perspective, the ability to modify the NP chemical
composition provided by the SCBD method will open large
possibilities for tailoring the active material in order to:
optimize the precious metal amount; expand the spectrum of
antimicrobial activity; reduce the risk for resistance devel-
opment; tailor the adhesion to surfaces to obtain a long
lasting, low cost antimicrobial film, in particular for metal
surfaces.
In conclusion we have demonstrated the realization of a
uniformAgNP filmwith extremely controlled thickness and NP
size directly on a substrate surface through a simple and scalable
technique, SCBD. The Ag2O oxidation state of the NPs and the
film morphology are stable in time. We have demonstrated that
such films present a relevant and broad-spectrum bactericidal
activity that could be related to the oxidation state of the Ag
NPs. This work opens the way for exploring the potential of
supersonic beams as alternative method for antibacterial
coating synthesis.Acknowledgement
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